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Abstract Lipopolysaccharide, the invariant structural compo-
nent of Gram-negative bacteria, when present in minute amounts
in the circulation in humans elicits ‘endotoxic shock’ syndrome,
which is fatal in 60% of the cases. Polymyxin B (PMB), a cyclic
cationic peptide, neutralizes the endotoxin, but also induces many
harmful side effects. Many peptide-based drugs mimicking the
activity of PMB have been synthesized in an attempt to reduce
toxicity while still retaining the anti-endotoxic activity. The
study attempts to use the recent technique of surface plasmon
resonance (SPR), in determining the kinetics of association and
dissociation involved in the interaction of endotoxin with a few
selected peptides that have structural features resembling PMB.
The results, in conjunction with the thermodynamic data derived
using isothermal titration calorimetry (ITC), stress the vital role
played by amphiphilicity of the peptides and hydrophobic forces
in this biologically important interaction.
z 1999 Federation of European Biochemical Societies.
Key words: Lipopolysaccharide; Polymyxin B; Surface
plasmon resonance; Isothermal titration calorimetry;
Kinetics; Amphiphilicity
1. Introduction
Lipopolysaccharide (LPS), the invariant structural compo-
nent of the Gram-negative bacterial outer membranes [1^5],
elicits numerous pleiotropic e¡ects on susceptible cells/organ-
isms including B-cell mitogenesis, activation of viruses, com-
plement and cytokine cascade, mimicry of acute graft versus
host disease, pyrogenicity and lethality in mammals and trig-
gering of the defense and clotting cascade in the horseshoe
crab [6,7]. The most dreaded sequel of LPS in the circulation,
caused by infection with Gram-negative bacteria, is termed
‘endotoxic shock’. Endotoxic shock is characterized by hemo-
dynamic and coagulation abnormalities [8], culminating in the
multiple system organ failure which accounts for about 60%
fatalities in humans [9]. All of the toxic and pleiotropic activ-
ities of LPS are con¢ned to its lipid A moiety (an acylated
phosphodisaccharide unit [10,11]). Removal of LPS by mole-
cules that interact strongly and speci¢cally constitutes an im-
portant stratagem for combating endotoxic shock [12^21].
Polymyxin B (PMB) and related family members of cyclic
cationic decapeptide antibiotics obtained from Bacillus poly-
myxa are used for treating severe cases of sepsis [22^24]. How-
ever, the usage of PMB in the prophylaxis of sepsis is limited
on account of its toxicity due to the harmful side e¡ects as-
sociated with its slow degradation in vivo, attributed to the
presence of uncommon D-amino acids, and its unusual cova-
lent structure [25,26]. We have previously shown that the am-
phiphilicity of PMB is both necessary and adequate for its
stoichiometric interaction with LPS [27,28]. As the analyses
of the kinetics and mechanism of macromolecule-ligand inter-
action provides valuable insights into the biomolecular recog-
nition processes, we report here on the surface plasmon reso-
nance analyses of the reaction of PMB, polymyxin B
nonapeptide (PMBN), as well as two synthetic cyclic peptide
analogs of PMB, with the endotoxin molecules. These studies
attempt to draw structure-activity correlation between them
and show that the amphiphilic distribution of the amino acid
side chains in them plays a crucial role in their recognition of
LPS [29^32].
2. Materials and methods
2.1. Materials
LPS from Escherichia coli strains 055:B5, obtained from Sigma
Chemical Co. (St. Louis, MO, USA), was repuri¢ed as described ear-
lier by Srimal et al. [27]. Diphosphoryl lipid A (heptacyl) derived from
E. coli was from List Biologicals, PMB and PMBN were obtained
from Sigma. All the other chemicals used were of the highest purity
available.
2.2. Peptide synthesis
The cyclic hepta- and decapeptide were synthesized on a solid phase
peptide synthesizer (NovaSyn) using standard Fmoc and Opfp chem-
istry. The peptides were cleaved from p-hydroxymethylphenoxymeth-
ylpolystyrene resin using 1,2-ethanedithiol (0.15 ml), deionized water
(0.5 ml) and tri£uoroacetic acid (10 ml). The sulfhydral bridge in the
decapeptide was introduced according to the method of Wu et al. [33].
They were puri¢ed by reverse phase HPLC on a C-18 (Vydac, USA)
column using a water/acetonitrile gradient. Their purity and molecular
weight were checked by matrix assisted laser desorption ionization
(MALDI) spectroscopy.
2.3. Preparation of LPS solution
LPS suspended in 50 mM phosphate bu¡er pH 6.8 was vortexed
vigorously for 10 min at 70‡C and mixed with equimolar concentra-
tion of triethylamine with respect to the anionic groups in them.
Samples were sonicated for 5 min using a Braun probe sonicator prior
to use.
2.4. Quanti¢cation of LPS/lipid A and PMB
LPS samples were quanti¢ed using the endotoxin from Endosafe, as
the standard, by the Limulus amebocyte lysate assay in pyrogen-free
water according to the method of Yin et al. [34], prior to all the
assays. PMB was quanti¢ed by its molar absorbance [27].
2.5. Surface plasmon resonance (SPR) analysis
Binding kinetics were determined by SPR using a BIAcore 2000
biosensor system. The peptides were covalently immobilized on the
certi¢ed grade CM5 sensor chips at concentrations of 40 Wg/ml in 10
mM sodium acetate, pH 4.8, using the amine coupling kit supplied by
the manufacturer. Nearly 500 resonance units (RU) of peptide were
immobilized under these conditions, where 1 RU corresponds to im-
mobilized peptide concentration of V1 pg/mm2. The unreacted moi-
eties on the surface were blocked with ethanolamine. All measure-
ments were carried out in 10 mM HEPES, pH 7.4, 150 mM NaCl,
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3.4 mM EDTA. For the determination of association rate constants
(k1), LPS (25^125 nM), £owing at a rate of 10 Wl/min, in the same
bu¡er was used. Dissociation rate constants (k31), were evaluated by
passing a solution of 1mM PMB, in the same bu¡er at a £ow rate of
10 Wl/min. The surface was regenerated by a 10-s pulse of 10 mM
NaOH £owing at 50 Wl/min.
2.5.1. Data analysis. Rate constants k1 and k31 were obtained by
¢tting the primary sensogram data using the BIA evaluation 3.0 soft-
ware. The dissociation rate constant is derived using equation 1:
Rt  Rt0 e3k31t3t0 1
where the Rt is the response at time t, Rt0 is the amplitude of the
initial response, and k31 is the dissociation rate constant. The associ-
ation rate constant k1 can be derived using equation 2, from the
measured k31 values:
Rt  RMax13 e3k1Ck31t3t0 2
where Rt is the response at time t, RMax is the maximum response, C
is the concentration of the analyte in the solution, k1 and k31 are the
association and dissociation rate constants respectively. The ratio of
k1 and k31 yields the value of association constant Ka (k1/k31).
All ITC experiments were performed as previously reported by
Srimal et al. [27], using an OMEGA high sensitivity microcalorimeter,
manufactured by MicroCal Inc [35]. A typical titration involved 15^20
injections at 3 min intervals, 4 Wl aliquots of peptide solution into the
sample cell (volume 1.344 ml) containing LPS (50 mM). The titration
cell was stirred continuously at 400 rev/min. The molecular mass of
LPS was taken to be 20 000 Da [27]. The heats of the dilution of the
peptides in the bu¡er alone were subtracted from the titration data.
The resulting data were then analyzed to determine the binding stoi-
chiometry (n), association constant and the enthalpy change (vHb) as
described earlier. vG0b and vS
0
b were calculated from the fundamental
equation of thermodynamics:
vG0b  3RTln Kb 3
vS0b  vHb3vG0b=T 4
3. Results
A typical sensogram for the binding of the varying concen-
trations of cyclic peptide immobilized on the CM5 sensor chip
is shown in Fig. 1. Occurrence of a rapid enhancement in the
RUs on the association of LPS to the cyclic peptide with time
re£ects the accompanying changes in the mass during the re-
action. The analyses of the sensogram data gives k1 and k31
for the interaction of LPS with the cyclic peptide as 3.2U105
M31 s31 and 0.092 s31 respectively. The distribution of the
residuals indicated that the time dependence of RUs for both
the association and the dissociation reactions is ¢tted satisfac-
torily to a monoexponential reaction. Non-binding of LPS to
the dextran matrix attests to the speci¢city of the interactions
of the peptides with LPS (Fig. 2, d). The association of the
LPS to peptides shows that it binds to PMB with not only the
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Fig. 1. Overlay plot of sensograms depicting the interaction of LPS with immobilized cyclic decapeptide. LPS ranging in concentration from 25
to 125 nM was injected for 50 s at a £ow rate of 10 Wl/min and concentrations from bottom to top: 25, 50, 75, 100 and 125 nM. After the dis-
sociation phase, by passing PMB (1 mM) in a running bu¡er, at 10 Wl/min, the surface was regenerated by a pulse of 10 mM NaOH at a £ow
rate of 10 Wl/min. Restrictions in the mobilities of the £uorescent probe diphenylhexatriene showed that the LPS used in the studies was con-
¢rmed to be in the lamellar phase [28,43].
Table 1
Kinetic parameters of LPS binding to peptides at 20‡C surface plasmon resonance analysis
Peptide Salt (M) k1U1034 (M31 s31) k31 (s31) KaU1035 (M31) 3vG0 (kJ mol31)
PMB 0.0 11.0 (11.9) 0.070 15.71 34.74
0.25 10.5 (11.1) 0.070 15.00 34.63
1.00 9.3 (9.9) 0.070 13.28 34.34
PMBN 0.0 3.2 (3.5) 0.083 3.85 31.33
0.25 3.1 (3.4) 0.082 3.78 31.03
1.00 2.8 (2.9) 0.082 3.41 31.08
Cyclic decapeptide 0.0 5.2 (5.0) 0.090 5.77 32.31
0.25 5.0 (4.7) 0.090 5.55 32.22
1.00 4.8 (4.2) 0.090 5.05 31.99
Cyclica heptapeptide ^ 0.2 W1 W0.02 18.5
Dansyl-PMB-LPS interaction by stopped £ow £uorimetry gives k1, k2, k31, k32 1.98U105 M31 s31, 0.341, 0.458, 0.0571 s31 respectively. The
overall binding constant Ka ([k1/k31]. [k2/k32]) is 2.5U106 M31 which is slightly higher than the value of Ka obtained by the SPR method. Dansyl-
PMBN-LPS interaction by stopped-£ow £uorimetry shows only single phases (k1 = 3.5U105 M31 s31 and k31 = 0.125 association and dissociation
s31). Value of k1 in parentheses indicates analysis of sensograms, using mass transport limited kinetics yields the same results. Values of k31 were
essentially the same.
aIndicates binding was too weak to be determined accurately.
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highest a⁄nity but also with greatest rapidity (Fig. 2, a).
Moreover, the residence time of LPS on PMB was longer
than that of other peptides (Table 1). The association rates
of the interaction of LPS to the peptides, excepting the cyclic
heptapeptide, range from 3.2U104 M31 s31 to 3.2U105 M31
s31, while the dissociation rates are 0.086^0.0987 s31. The
cyclic heptapeptide has abysmally low k1 (W2U103 M31
s31) and high k31 (v 1 s31). The dissociation rate constants
were also determined by the plot of ln (R1/Rt) versus time.
The values of the k31 thus obtained were 0.083, 0.098, 0.092
s31 for PMB, PMBN and the cyclic peptide, respectively and
were similar to those obtained by ¢tting the original plots.
The e¡ects of varying salt concentrations on the kinetics of
LPS-PMB interaction are also shown in Table 1. Mass trans-
port limited kinetic analysis of these sensograms yielded sim-
ilar rate constants (Table 2, Fig. 3).
Isothermal titration calorimetry for the binding of these
peptides was conducted to obtain an independent measure
of their a⁄nities, binding enthalpies as well as the changes
in the heat capacities. The binding constant (Ka) for cyclic
decapeptide, PMBN and cyclic heptapeptide are 3.5U105,
2.1U105, 2U103 M31 respectively which are in excellent
agreement with the value obtained by SPR analyses. The val-
ues of Ka for PMB-LPS interaction are close to those ob-
tained by an earlier ITC study. All the peptides show endo-
thermic changes in enthalpies which lie in the range 24^12 kJ/
mol as well as negative changes in heat capacities (vCp). How-
ever, the vH and vCp values for the cyclic heptapeptide could
not be determined due to its poor a⁄nity for the endotoxin
(Table 1).
4. Discussion
SPR is a rapid method for evaluating the elementary step
involved in the interaction between a macromolecule and its
complementary ligand as well as the a⁄nities involved therein
as proven by a wealth of data in the literature [36^41]. As the
method relies exclusively on the mass change, the biomolecu-
lar interaction can be studied in real time without taking
recourse to any external labels such as radioisotopes or £uo-
rophores which, in some instances, can alter the nature of the
reaction. Moreover, SPR is perhaps the only technique that
can provide data for both the association and dissociation
phases of a reaction in a single experimental run.
These studies are based on the premise that characterization
of the interaction of PMB and related peptides to LPS could
lend to an understanding of the mechanism of their interac-
tion with endotoxin. It is therefore, pertinent to relate the
structure of PMB and related peptides used in this study
with their LPS interaction abilities, which are depicted below.
where X- corresponds to 6-heptanoyl/octanoyl moieties at-
tached at the N-terminus of PMB and DAB. Cyclic deca-
and heptapeptide are represented by single letter code and
are based on the work of Porro et al. [25].
Using stopped-£ow £uorescence spectrometry we have re-
cently reported that PMB-LPS interaction consists of a pair of
kinetically distinguishable on and o¡ reactions [28]. On the
other hand PMBN-LPS interactions exhibit monoexponential
association and dissociation rates (unpublished observations).
The SPR data show that PMB and the other peptides interact
with LPS in a monoexponential manner. This is not surprising
as SPR measures mass changes alone as a function of time.
Consequently, subtle conformational changes involved in the
macromolecular-ligand interactions are di⁄cult to observe.
The values of k1 and k31 for the binding of PMB-LPS inter-
actions estimated from the SPR experiment are close to those
determined by the stopped-£ow spectro£uorimetry for the
faster phase of the reaction. However, as the PMBN as well
as other peptides display a monoexponential binding behavior
only and the SPR values of k1 and k31 for PMB-LPS inter-
actions are notably similar to those of the fast phase of the
reaction evaluated using the former method. These data taken
together with the fact that the contribution of the slower
phase of the reaction for PMB-LPS interaction is small to
the overall binding constant, it is adequate to compare the
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Fig. 2. Comparison of SPR derived binding curves for di¡erent im-
mobilized peptides interacting with LPS. LPS at ¢xed concentration
(125 nM, except for cyclic heptapeptide, where the concentration
used was 500 WM) was injected for 50 s at a £ow rate of 10 Wl/min.
The sensograms represent binding of, from bottom to top: cyclic
heptapeptide, PMBN, cyclic decapeptide, PMB and to blank control
chip. The association (k1) and dissociation rate constants (k31) were
derived by ¢tting the sensograms to a Langumir binding rate equa-
tions (Eqs. 1 and 2) and are tabulated in Table 1.
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binding properties of the peptides using the SPR analysis.
Inspection of the binding parameters determined in the SPR
experiments show that the endotoxin molecule binds to PMB
the strongest, due to a faster on as well as a slower o¡ rate.
While LPS also shows a similar k1 for the binding to cyclic
decapeptide its faster dissociation perhaps accounts for its
relatively lower a⁄nity. The poorer a⁄nity for PMBN for
LPS is accounted for by a relatively slower k1 and a faster
k31 as compared to PMB. The cyclic heptapeptides extremely
poor a⁄nity for LPS is largely due to its slow k1 and the very
fast k31 reactions (k1 = 2U103 M31 s31, k31v 1 s31) as com-
pared to PMB.
The values of binding constants for the interaction of these
peptides with isothermal titration calorimetry experiments are
in close agreement with those from SPR analyses. This indi-
cates that the SPR experiments are reporting a total binding
event. Moreover, the ITC data show that the binding of the
peptides to LPS is driven by hydrophobic forces [28]. The
kinetics of binding of LPS with PMB and related peptides
appears to be dominated by van der Waals and hydrophobic
interactions as, even at 1 M salt concentration where the
electrostatic interactions can be considered to be completely
neutralized, both the on and the o¡ rates are a¡ected margin-
ally [27]. Therefore, the electrostatic interaction between LPS
and PMB, perhaps plays a minor role during the reaction.
Thus the role of the positively charged DAB side chains of
PMB and other analogous peptides is largely related to their
ability to maintain the amphiphilicity of these peptides.
In an earlier study we had proposed that the amphipathic
distribution, viz. the asymmetric location of the positively
charged polar and the non-polar amino acid side chains at
disparate regions are responsible for its strong and stoichio-
metric binding to LPS [27,28,42]. That amphiphilicity is both
necessary and su⁄cient for the interaction of the peptides to
LPS is proven further by the binding of LPS to a synthetic
peptide with a vectorial segregation of polar and non-polar
amino acid side chains but which bears no structural resem-
blance to PMB [25]. Since PMBN lacks the acyl chain at its
amino-terminus, it has poorer a⁄nity and kinetics of binding
to LPS which is be related to its relatively lower amphiphilic-
ity as compared to that of PMB. The k1 for the binding of
LPS to the cyclic decapeptide is comparable to that of PMB.
This is not surprising as its amphiphilicity is higher when
compared to PMBN due to the presence of lysyl side chains
which contains two extra methelene groups in place of the
DAB side chains of the latter. An extremely poor kinetics
and a⁄nity of binding of LPS to the cyclic heptapeptide
which does not display any amphiphilicity proves further
that amphiphilicity is both necessary and su⁄cient for the
binding of peptides to LPS.
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